CHARACTERISTICS OF INSOMNIA SUBJECTS SCREENED FOR TRANSITIONING FROM ZOLPIDEM TARTRATE TO LEMBOREXANT IN A MULTICENTER PILOT STUDY

被引：0
|
作者：
Ahmad, M. [1 ]
Malhotra, M. [2 ]
Amchin, J. [2 ]
Kumar, D. [2 ]
Perdomo, C. [2 ]
Moline, M. [2 ]
机构：
[1] Clinilabs Drug Dev Corp, New York, NY USA
[2] Eisai Inc, Woodcliff Lake, NJ USA
来源：
SLEEP | 2020年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
0477
引用
收藏
页码：A183 / A183
页数：1
相关论文
共 50 条
  • [21] SAFETY OF LEMBOREXANT IN ELDERLY SUBJECTS WITH INSOMNIA: RESULTS FROM A PHASE 3 STUDY (SUNRISE 1)
    Rosenberg, Russell
    Filippov, Gleb
    LoPresti, Antonia
    Kumar, Dinesh
    Murphy, Patricia
    Moline, Margaret
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (03): : S155 - S156
  • [22] EVALUATION OF DOSE TRANSITION FROM ZOLPIDEM TO LEMBOREXANT IN FEMALES AND MALES WITH INSOMNIA: POST HOC ANALYSES FROM AN OPEN-LABEL STUDY
    Rosenberg, R.
    Ahmad, M.
    Kumar, D.
    Perdomo, C.
    Moline, M.
    Malhotra, M.
    SLEEP MEDICINE, 2022, 100 : S119 - S120
  • [23] IMPACT OF LEMBOREXANT ON INSOMNIA DISEASE SEVERITY AND FATIGUE IN ELDERLY SUBJECTS WITH INSOMNIA FROM SUNRISE-2
    Yardley, Jane
    Pinner, Kate
    Moline, Margaret
    Perdomo, Carlos
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 28 (04): : S134 - S135
  • [24] Pharmacokinetics of Zolpidem from Sublingual Zolpidem Tartrate Tablets In Healthy Elderly Versus Non-Elderly Subjects
    Greenblatt, David J.
    Harmatz, Jerold S.
    Singh, Nikhilesh N.
    Steinberg, Frank
    Roth, Thomas
    Harris, Stephen C.
    Kapil, Ram P.
    DRUGS & AGING, 2014, 31 (10) : 731 - 736
  • [25] Pharmacokinetics of Zolpidem from Sublingual Zolpidem Tartrate Tablets In Healthy Elderly Versus Non-Elderly Subjects
    David J. Greenblatt
    Jerold S. Harmatz
    Nikhilesh N. Singh
    Frank Steinberg
    Thomas Roth
    Stephen C. Harris
    Ram P. Kapil
    Drugs & Aging, 2014, 31 : 731 - 736
  • [26] A MULTICENTER, PLACEBO-CONTROLLED STUDY EVALUATING ZOLPIDEM IN THE TREATMENT OF CHRONIC INSOMNIA
    SCHARF, MB
    ROTH, T
    VOGEL, GW
    WALSH, JK
    JOURNAL OF CLINICAL PSYCHIATRY, 1994, 55 (05) : 192 - 199
  • [27] A 3 WEEK MULTICENTER GENERAL-PRACTITIONER STUDY OF ZOLPIDEM IN 651 PATIENTS WITH INSOMNIA
    CLUYDTS, RJ
    DEROECK, JM
    ACTA THERAPEUTICA, 1993, 19 (01) : 73 - 91
  • [28] Comparison of lemborexant with placebo and zolpidem tartrate extended release for the treatment of older adults with insomnia disorder: a phase 3 randomized clinical trial (vol 2, e1918254, 2019)
    Rosenberg, R.
    Murphy, P.
    Zammit, G.
    JAMA NETWORK OPEN, 2020, 3 (04)
  • [29] Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial (vol 2, e1918254, 2019)
    Rosenberg, Russell
    Murphy, Patricia
    Zammit, Gary
    JAMA NETWORK OPEN, 2021, 4 (08)
  • [30] Impact of lemborexant treatment on insomnia severity: analyses from a 12-month study of adults with insomnia disorder
    Roth, Thomas
    Rosenberg, Russell
    Morin, Charles M.
    Yardley, Jane
    Pinner, Kate
    Perdomo, Carlos
    Atkins, Norman, Jr.
    Pappadopulos, Elizabeth
    Malhotra, Manoj
    Moline, Margaret
    SLEEP MEDICINE, 2022, 90 : 249 - 257
12345